Cargando…
S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428252/ http://dx.doi.org/10.1097/01.HS9.0000967432.73477.1d |
| _version_ | 1785090423011672064 |
|---|---|
| author | Montesinos, Pau Rodríguez-Veiga, Rebeca Bergua Burgues, Juan Miguel Algarra, Lorenzo Botella, Carmen Josè Antonio, Perez Simon Bernal, Teresa Tormo, Mar Robles, Maria Calbacho Salamero, Olga Serrano, Josefina Noriega, Victor López-López, Juan Antonio Polo, Susana Vives Colorado, Mercedes Lorenzo, Jose Luis Lopez Vidriales, María Belén Boyero, Raimundo Garcia Olave, Mayte Herrera-Puente, Pilar Arce, Olga Garcia, Manuel Barrios Jose Sayas Lloris, Maria Polo, Marta Isabel Gomez Roncero, Maria Barragan, Eva Ayala Diaz, Rosa Carmen Chillon, Maria Jose Calasanz, Maria Boluda, Blanca Martinez-Cuadrón, David Labrador, Jorge |
| author_facet | Montesinos, Pau Rodríguez-Veiga, Rebeca Bergua Burgues, Juan Miguel Algarra, Lorenzo Botella, Carmen Josè Antonio, Perez Simon Bernal, Teresa Tormo, Mar Robles, Maria Calbacho Salamero, Olga Serrano, Josefina Noriega, Victor López-López, Juan Antonio Polo, Susana Vives Colorado, Mercedes Lorenzo, Jose Luis Lopez Vidriales, María Belén Boyero, Raimundo Garcia Olave, Mayte Herrera-Puente, Pilar Arce, Olga Garcia, Manuel Barrios Jose Sayas Lloris, Maria Polo, Marta Isabel Gomez Roncero, Maria Barragan, Eva Ayala Diaz, Rosa Carmen Chillon, Maria Jose Calasanz, Maria Boluda, Blanca Martinez-Cuadrón, David Labrador, Jorge |
| author_sort | Montesinos, Pau |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428252 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104282522023-08-17 S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML Montesinos, Pau Rodríguez-Veiga, Rebeca Bergua Burgues, Juan Miguel Algarra, Lorenzo Botella, Carmen Josè Antonio, Perez Simon Bernal, Teresa Tormo, Mar Robles, Maria Calbacho Salamero, Olga Serrano, Josefina Noriega, Victor López-López, Juan Antonio Polo, Susana Vives Colorado, Mercedes Lorenzo, Jose Luis Lopez Vidriales, María Belén Boyero, Raimundo Garcia Olave, Mayte Herrera-Puente, Pilar Arce, Olga Garcia, Manuel Barrios Jose Sayas Lloris, Maria Polo, Marta Isabel Gomez Roncero, Maria Barragan, Eva Ayala Diaz, Rosa Carmen Chillon, Maria Jose Calasanz, Maria Boluda, Blanca Martinez-Cuadrón, David Labrador, Jorge Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428252/ http://dx.doi.org/10.1097/01.HS9.0000967432.73477.1d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Montesinos, Pau Rodríguez-Veiga, Rebeca Bergua Burgues, Juan Miguel Algarra, Lorenzo Botella, Carmen Josè Antonio, Perez Simon Bernal, Teresa Tormo, Mar Robles, Maria Calbacho Salamero, Olga Serrano, Josefina Noriega, Victor López-López, Juan Antonio Polo, Susana Vives Colorado, Mercedes Lorenzo, Jose Luis Lopez Vidriales, María Belén Boyero, Raimundo Garcia Olave, Mayte Herrera-Puente, Pilar Arce, Olga Garcia, Manuel Barrios Jose Sayas Lloris, Maria Polo, Marta Isabel Gomez Roncero, Maria Barragan, Eva Ayala Diaz, Rosa Carmen Chillon, Maria Jose Calasanz, Maria Boluda, Blanca Martinez-Cuadrón, David Labrador, Jorge S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML |
| title | S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML |
| title_full | S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML |
| title_fullStr | S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML |
| title_full_unstemmed | S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML |
| title_short | S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML |
| title_sort | s130: preliminary results of quiwi: a double blinded, randomized clinical trial comparing standard chemotherapy plus quizartinib versus placebo in adult patients with newly diagnosed flt3-itd wild-type aml |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428252/ http://dx.doi.org/10.1097/01.HS9.0000967432.73477.1d |
| work_keys_str_mv | AT montesinospau s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT rodriguezveigarebeca s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT berguaburguesjuanmiguel s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT algarralorenzo s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT botellacarmen s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT joseantonioperezsimon s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT bernalteresa s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT tormomar s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT roblesmariacalbacho s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT salameroolga s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT serranojosefina s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT noriegavictor s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT lopezlopezjuanantonio s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT polosusanavives s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT coloradomercedes s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT lorenzojoseluislopez s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT vidrialesmariabelen s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT boyeroraimundogarcia s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT olavemayte s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT herrerapuentepilar s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT arceolga s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT garciamanuelbarrios s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT josesayasllorismaria s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT polomarta s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT isabelgomezronceromaria s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT barraganeva s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT ayaladiazrosa s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT carmenchillonmaria s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT josecalasanzmaria s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT boludablanca s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT martinezcuadrondavid s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml AT labradorjorge s130preliminaryresultsofquiwiadoubleblindedrandomizedclinicaltrialcomparingstandardchemotherapyplusquizartinibversusplaceboinadultpatientswithnewlydiagnosedflt3itdwildtypeaml |